Genmab Genmab is a biotechnology company that develops and commercializes antibody therapeutics to treat cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 1904 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Copenhagen, DK HQ Tokyo, JP Utrecht, NL Plainsboro, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 2,638 | Employees 7,5692% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit $3.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Operating ⚠ | ||
Trademarks | Trademarks 285 (FY, 2018) | Trademarks 4 (Dec, 2020) |